Mark Lüdde
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cardiomyopathy and Myosin Studies
Papers in
-
- MicroRNA in disease regulation 11
- NF-κB Signaling Pathways 4
-
- Heart Failure Treatment and Management 6
- Cardiovascular Function and Risk Factors 5
- Cardiovascular Effects of Exercise 4
- Co-authors
- Norbert Frey (31 shared papers)Tom Luedde (49 shared papers)Hugo Albert Katus (12 shared papers)Christoph Roderburg (26 shared papers)Mihael Vucur (23 shared papers)Christian Trautwein (26 shared papers)Frank Tacke (26 shared papers)David Vargas Cardenas (14 shared papers)
- Journals
- Journal of Clinical Medicine (6 papers)Clinical Research in Cardiology (5 papers)Disease Markers (5 papers)PLoS ONE (4 papers)Scientific Reports (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Mark Lüdde
92 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 747
- Cardiology and Cardiovascular Medicine 636
- Hepatology 206
- Molecular Biology 1.7k
- Epidemiology 665
Countries citing papers authored by Mark Lüdde
This map shows the geographic impact of Mark Lüdde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lüdde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lüdde more than expected).
Fields of papers citing papers by Mark Lüdde
This network shows the impact of papers produced by Mark Lüdde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lüdde. The network helps show where Mark Lüdde may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lüdde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 277 | |
| 2 | 2014 | 269 | |
| 3 | 2017 | 259 | |
| 4 | 2011 | 183 | |
| 5 | 2007 | 154 | |
| 6 | 2013 | 146 | |
| 7 | 2013 | 144 | |
| 8 | 2016 | 132 | |
| 9 | 2013 | 123 | |
| 10 | 2014 | 116 | |
| 11 | 2012 | 112 | |
| 12 | 2014 | 107 | |
| 13 | 2012 | 97 | |
| 14 | 2000 | 96 | |
| 15 | 2023 | 96 | |
| 16 | 2021 | 87 | |
| 17 | 2016 | 86 | |
| 18 | 2018 | 69 | |
| 19 | 2010 | 63 | |
| 20 | 2016 | 62 |
About Mark Lüdde
Mark Lüdde is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Oncology, Epidemiology and Molecular Biology, having authored 97 papers that have together received 3.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Heart Failure Treatment and Management (6 papers), Cell death mechanisms and regulation (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Cardiovascular Function and Risk Factors (5 papers), NF-κB Signaling Pathways (4 papers), Cardiovascular Effects of Exercise (4 papers) and Bone and Dental Protein Studies (4 papers). The work is most often cited by research in Cancer Research (747 citations), Cardiology and Cardiovascular Medicine (636 citations), Hepatology (206 citations), Molecular Biology (1.7k citations) and Epidemiology (665 citations). Mark Lüdde has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Norbert Frey, Tom Luedde, Hugo Albert Katus, Christoph Roderburg, Mihael Vucur, Christian Trautwein, Frank Tacke, David Vargas Cardenas, Alexander Hemdorff Koch and Jérémie Gautheron. Their work appears in journals such as Journal of Clinical Medicine, Clinical Research in Cardiology, Disease Markers, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.